Efficiency of bis-amidate phosphonate prodrugs
- PMID: 35405283
- PMCID: PMC10245299
- DOI: 10.1016/j.bmcl.2022.128724
Efficiency of bis-amidate phosphonate prodrugs
Abstract
Bis-amidate derivatives have been viewed as attractive phosphonate prodrug forms because of their straightforward synthesis, lack of phosphorus stereochemistry, plasma stability and nontoxic amino acid metabolites. However, the efficiency of bis-amidate prodrug forms is unclear, as prior studies on this class of prodrugs have not evaluated their activation kinetics. Here, we synthetized a small panel of bis-amidate prodrugs of butyrophilin ligands as potential immunotherapy agents. These compounds were examined relative to other prodrug forms delivering the same payload for their stability in plasma and cell lysate, their ability to stimulate T cell proliferation in human PBMCs, and their activation kinetics in a leukemia co-culture model of T cell cytokine production. The bis-amidate prodrugs demonstrate high plasma stability and improved cellular phosphoantigen activity relative to the free phosphonic acid. However, the efficiency of bis-amidate activation is low relative to other prodrugs that contain at least one ester such as aryl-amidate, aryl-acyloxyalkyl ester, and bis-acyloxyalkyl ester forms. Therefore, bis-amidate prodrugs do not drive rapid cellular payload accumulation and they would be more useful for payloads in which slower, sustained-release kinetics are preferred.
Keywords: Butyrophilin; Isoprenoid; Ligand; Phosphoantigen; Phosphonamidate prodrug.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Figures
References
-
- Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG, The relationship between the chemistry and biological activity of the bisphosphonates. Bone 2011, 49 (1), 20–33. - PubMed
-
- Jansa P; Baszczynski O; Dracinsky M; Votruba I; Zidek Z; Bahador G; Stepan G; Cihlar T; Mackman R; Holy A; Janeba Z, A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities. Eur. J. Med. Chem 2011, 46 (9), 3748–54. - PubMed
-
- Cesnek M; Jansa P; Smidkova M; Mertlikova-Kaiserova H; Dracinsky M; Brust TF; Pavek P; Trejtnar F; Watts VJ; Janeba Z, Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis. ChemMedChem 2015, 10 (8), 1351–64. - PubMed
-
- Houot R; Schultz LM; Marabelle A; Kohrt H, T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. Cancer immunology research 2015, 3 (10), 1115–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
